{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:28Z","timestamp":1790957668725,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["5R01CA214606"],"award-info":[{"award-number":["5R01CA214606"]}]},{"name":"Bear\u2019s Care and The Matthews and Schutz Family Foundations","award":["5R01CA214606"],"award-info":[{"award-number":["5R01CA214606"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Epidemiological and observational studies suggest that vitamin D has potential for the chemoprevention of ovarian cancer. The anticancer effect of vitamin D in the fallopian tube epithelium (FTE), which is now thought to harbor the precursor cells for high grade ovarian cancer, is not known. The purpose of this study was to investigate whether vitamin D can inhibit carcinogenesis in the mogp-TAg fallopian tube (FT) ovarian cancer mouse model and examine underlying mechanisms. To test this hypothesis, 3 groups of 40 5-week-old female mogp-TAg mice were divided equally into two cohorts of 20 mice, treated with either vehicle (vitamin D solvent) or the active 1,25(OH)2D3 analogue EB1089, delivered via mini-pump or IP injection or cholecalciferol delivered in the feed. The FTs were characterized histologically and pathologically after 3 and 7 weeks of treatment. The effect of vitamin D on cultured human FTE cells was also examined. After 3 weeks, vitamin D, delivered as either cholecalciferol or EB1089 significantly inhibited FT carcinogenesis. After 7 weeks, cholecalciferol significantly reduced p53 signatures, serous tubal epithelial carcinoma, FT cancer, and plasma CA125 while increasing apoptosis in the FTE. EB1089 had no significant effect on FT carcinogenesis at 7 weeks. Cholecalciferol significantly reduced proliferation and increased apoptosis in vitro in p53-altered FTE cells. In conclusion, vitamin D inhibited FT carcinogenesis by clearing cells with p53 alterations. These data suggest that vitamin D has merit for the chemoprevention of fallopian tube\/ovarian cancer. The optimal chemopreventive effect may be dependent on the route of vitamin D administration<\/jats:p>","DOI":"10.3390\/nu16193318","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T05:45:27Z","timestamp":1727675127000},"page":"3318","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vitamin D Significantly Inhibits Carcinogenesis in the Mogp-TAg Mouse Model of Fallopian Tube Ovarian Cancer"],"prefix":"10.3390","volume":"16","author":[{"given":"Omar L.","family":"Nelson","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Endeavor Health, Evanston, IL 60201, USA"},{"name":"Department of Obstetrics and Gynecology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rosales","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Endeavor Health, Evanston, IL 60201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Turbov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Endeavor Health, Evanston, IL 60201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry G","family":"Thaete","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Endeavor Health, Evanston, IL 60201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathriy","family":"Balamayooran","sequence":"additional","affiliation":[{"name":"Pathology\/Comparative Medicine and Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4844-1238","authenticated-orcid":false,"given":"J Mark","family":"Cline","sequence":"additional","affiliation":[{"name":"Pathology\/Comparative Medicine and Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wesley","family":"Pike","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-4764","authenticated-orcid":false,"given":"Gustavo C.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Endeavor Health, Evanston, IL 60201, USA"},{"name":"Department of Obstetrics and Gynecology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (2024). Cancer Facts & Figures 2024, American Cancer Society."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","article-title":"Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-3-642-55580-0_27","article-title":"Ecologic studies of solar UV-B radiation and cancer mortality rates","volume":"164","author":"Grant","year":"2003","journal-title":"Recent Results Cancer Res."},{"key":"ref_6","first-page":"2687","article-title":"The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates","volume":"26","author":"Grant","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.amepre.2006.08.018","article-title":"Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer","volume":"31","author":"Garland","year":"2006","journal-title":"Am. J. Prev. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/1940-6207.CAPR-12-0279","article-title":"Association between ambient ultraviolet radiation and risk of epithelial ovarian cancer","volume":"5","author":"Tran","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz, A., and Grant, W.B. (2022). Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients, 14.","DOI":"10.3390\/nu14071448"},{"key":"ref_10","unstructured":"Feldman, D., Pike, J.W., and Glorieux, F.H. (2005). The Pharmacology of Vitamin D, Including Fortification Strategies. Vitamin D, Academic Press. Chapter 61."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Robert, B., Rucker, J.M., and Andrea, J.F. (2008). Vitamins. Clinical Biochemistry of Domestic Animals, Academic Press. [6th ed.]. Chapter 23\u2014Vitamins.","DOI":"10.1016\/B978-0-12-370491-7.00023-4"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.11520","article-title":"Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells","volume":"108","author":"Miettinen","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mrd.10175","article-title":"Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: Tumor formation and its hormonal regulation","volume":"63","author":"Miyoshi","year":"2002","journal-title":"Mol. Reprod. Dev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Kuhn","year":"2014","journal-title":"J. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1158\/1940-6207.CAPR-21-0324","article-title":"Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer","volume":"15","author":"Nelson","year":"2022","journal-title":"Cancer Prev. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat. Protoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/onc.2015.288","article-title":"YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells","volume":"35","author":"Hua","year":"2016","journal-title":"Oncogene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2147\/OTT.S100581","article-title":"Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo","volume":"9","author":"Li","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jeremy, M., Gurusubramanian, G., and Roy, V.K. (2019). Vitamin D3 regulates apoptosis and proliferation in the testis of D-galactose-induced aged rat model. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-50679-y"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2002-07-1984","article-title":"The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro","volume":"101","author":"Pepper","year":"2003","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1139\/bcb-2022-0049","article-title":"Cholecalciferol induces apoptosis via autocrine metabolism in epidermoid cervical cancer cells","volume":"100","author":"Bhoora","year":"2022","journal-title":"Biochem. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"bqaa218","DOI":"10.1210\/endocr\/bqaa218","article-title":"Vitamin D-regulated Gene Expression Profiles: Species-specificity and Cell-specific Effects on Metabolism and Immunity","volume":"162","author":"Dimitrov","year":"2021","journal-title":"Endocrinology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Reichrath, J., Reichrath, S., Vogt, T., and R\u00f6mer, K. (2020). Crosstalk between Vitamin D and p53 Signaling in Cancer: An Update. Advances in Experimental Medicine and Biology, Springer.","DOI":"10.1007\/978-3-030-46227-7_15"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bhoora, S., Pather, Y., Marais, S., and Punchoo, R. (2020). Cholecalciferol Inhibits Cell Growth and Induces Apoptosis in the CaSki Cell Line. Med. Sci., 8.","DOI":"10.3390\/medsci8010012"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Dovnik, A., and Dovnik, N.F. (2020). Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms. Cells, 9.","DOI":"10.3390\/cells9020335"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Henn, M., Martin-Gorgojo, V., and Martin-Moreno, J.M. (2022). Vitamin D in Cancer Prevention: Gaps in Current Knowledge and Room for Hope. Nutrients, 14.","DOI":"10.3390\/nu14214512"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/ERC-21-0182","article-title":"The role of vitamin D in breast cancer risk and progression","volume":"29","author":"Vanhevel","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"L\u2019esp\u00e9rance, K., Datta, G.D., Qureshi, S., and Koushik, A. (2020). Vitamin D Exposure and Ovarian Cancer Risk and Prognosis. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17041168"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41574-021-00593-z","article-title":"The health effects of vitamin D supplementation: Evidence from human studies","volume":"18","author":"Bouillon","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41467-020-20368-w","article-title":"A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization","volume":"12","author":"Ong","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Manson, J.E., Bassuk, S.S., and Buring, J.E. (2020). Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials. J. Steroid Biochem. Mol. Biol., 198.","DOI":"10.1016\/j.jsbmb.2019.105522"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2250681","DOI":"10.1001\/jamanetworkopen.2022.50681","article-title":"Association of Body Weight With Response to Vitamin D Supplementation and Metabolism","volume":"6","author":"Tobias","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/jama.2017.2115","article-title":"Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial","volume":"317","author":"Lappe","year":"2017","journal-title":"JAMA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jsbmb.2017.08.009","article-title":"Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations","volume":"177","author":"Grant","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Carlberg, C. (2019). Nutrigenomics of Vitamin D. Nutrients, 11.","DOI":"10.3390\/nu11030676"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e182178","DOI":"10.1001\/jamaoncol.2018.2178","article-title":"Monthly High-Dose Vitamin D Supplementation and Cancer Risk: A Post Hoc Analysis of the Vitamin D Assessment Randomized Clinical Trial","volume":"4","author":"Scragg","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2213-8587(21)00345-4","article-title":"The D-Health Trial: A randomised controlled trial of the effect of vitamin D on mortality","volume":"10","author":"Neale","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"l4673","DOI":"10.1136\/bmj.l4673","article-title":"Association between vitamin D supplementation and mortality: Systematic review and meta-analysis","volume":"366","author":"Zhang","year":"2019","journal-title":"BMJ"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"E780","DOI":"10.1152\/ajpendo.1990.258.5.E780","article-title":"Role of 25-hydroxyvitamin D3 dose in determining rat 1,25-dihydroxyvitamin D3 production","volume":"258","author":"Vieth","year":"1990","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jsbmb.2005.06.004","article-title":"Biological actions of extra-renal 25-hydroxyvitamin D-1\u03b1-hydroxylase and implications for chemoprevention and treatment","volume":"97","author":"Townsend","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_41","unstructured":"Feldman, D. (2005). CHAPTER 5\u2014The 25-Hydroxyvitamin D 1\u03b1-Hydroxylase. Vitamin D, Academic Press. [2nd ed.]."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccr.2009.11.025","article-title":"Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53","volume":"17","author":"Stambolsky","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"48030","DOI":"10.1074\/jbc.M308430200","article-title":"G2\/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer","volume":"278","author":"Jiang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1158\/1078-0432.323.11.1","article-title":"Growth Suppression of Ovarian Cancer Xenografts in Nude Mice by Vitamin D Analogue EB1089","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. Cancer Res."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/19\/3318\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:07:29Z","timestamp":1760112449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/19\/3318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":44,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["nu16193318"],"URL":"https:\/\/doi.org\/10.3390\/nu16193318","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}